115 related articles for article (PubMed ID: 27863007)
1. T-lymphoid or T/myeloid blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy: a report of 14 cases.
Gong Z; Xie W; Wang W; Chen Z; Xu J; Yuan J; Zhou Y; Wang D; Medeiros LJ; Hu S
Int J Lab Hematol; 2017 Apr; 39(2):e45-e50. PubMed ID: 27863007
[No Abstract] [Full Text] [Related]
2. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
3. Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
Chen Z; Cortes JE; Jorgensen JL; Wang W; Yin CC; You MJ; Jabbour E; Kantarjian HM; Medeiros LJ; Hu S
Leukemia; 2016 Jul; 30(7):1606-9. PubMed ID: 26837843
[No Abstract] [Full Text] [Related]
4. Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.
Chen Z; Wang W; Cortes JE; Liu E; Miranda RN; Zhao C; Yuan J; Lu X; Yang W; Ameri MD; Kantarjian HM; Medeiros LJ; Hu S
Blood Cancer J; 2016 May; 6(5):e418. PubMed ID: 27152845
[No Abstract] [Full Text] [Related]
5. Clinical efficacy of second generation tyrosine kinase inhibitor and 5-azacytidine combination in chronic myelogenous leukaemia in myeloid blast crisis.
Ghez D; Micol JB; Pasquier F; Auger N; Saada V; Spentchian M; Ianotto JC; Bourhis JH; Bennaceur-Griscelli A; Terré C; Castaigne S; Rigaudeau S; Rousselot P; de Botton S
Eur J Cancer; 2013 Nov; 49(17):3666-70. PubMed ID: 23968731
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia.
Koca E; Sevimli F; Cetiner D; Haznedaroglu IC; Sayinalp N; Büyükasik Y; Goker H; Ozcebe O
Am J Hematol; 2007 Apr; 82(4):333. PubMed ID: 17094091
[No Abstract] [Full Text] [Related]
7. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia.
Neviani P; Santhanam R; Oaks JJ; Eiring AM; Notari M; Blaser BW; Liu S; Trotta R; Muthusamy N; Gambacorti-Passerini C; Druker BJ; Cortes J; Marcucci G; Chen CS; Verrills NM; Roy DC; Caligiuri MA; Bloomfield CD; Byrd JC; Perrotti D
J Clin Invest; 2007 Sep; 117(9):2408-21. PubMed ID: 17717597
[TBL] [Abstract][Full Text] [Related]
8. p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cells.
Peterson LF; Mitrikeska E; Giannola D; Lui Y; Sun H; Bixby D; Malek SN; Donato NJ; Wang S; Talpaz M
Leukemia; 2011 May; 25(5):761-9. PubMed ID: 21350558
[TBL] [Abstract][Full Text] [Related]
9. The biology of chronic myelogenous leukemia progression: who, what, where, and why?
Radich JP
Hematol Oncol Clin North Am; 2011 Oct; 25(5):967-80, v. PubMed ID: 22054729
[TBL] [Abstract][Full Text] [Related]
10. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
Liu YL; Wang XN; Liu HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
[TBL] [Abstract][Full Text] [Related]
11. Dasatinib in the management of lymphoid blast crisis of Philadelphia-positive chronic myeloid leukemia with multiple extra-medullary and intracranial localizations.
Alimena G; Breccia M; Latagliata R; Grammatico S; Matturro A; Capria S; De Propris MS; Diverio D; Meloni G
Leuk Res; 2009 Aug; 33(8):e134-6. PubMed ID: 19286256
[No Abstract] [Full Text] [Related]
12. Sudden lymphoid blast crisis after tyrosine kinase inhibitor discontinuation in chronic phase chronic myeloid leukemia: cautionary tales for appropriate molecular monitoring.
Bataller A; Haddad FG; Issa GC; Sasaki K; Jabbour E; Borthakur G; Ferrajoli A; Short NJ
Leuk Lymphoma; 2023 Mar; 64(3):746-749. PubMed ID: 36657414
[No Abstract] [Full Text] [Related]
13. Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib.
Koh Y; Kim I; Yoon SS; Kim BK; Kim DY; Lee JH; Lee KH; Park E; Kim HJ; Sohn SK; Joo YD; Kim SJ; Chung J; Shin HJ; Kim SH; Kim CS; Song HS; Kim MK; Hyun MS; Ahn JS; Jung CW; Park S;
Ann Hematol; 2010 Jul; 89(7):725-31. PubMed ID: 20179930
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
[TBL] [Abstract][Full Text] [Related]
15. The issue of financial toxicity in the management of chronic myeloid leukemia with blast crisis.
Eskazan AE
J Med Econ; 2018 Jul; 21(7):709-711. PubMed ID: 29673265
[No Abstract] [Full Text] [Related]
16. Methylation patterns in CD34 positive chronic myeloid leukemia blast crisis cells.
Janssen JJ; Denkers F; Valk P; Cornelissen JJ; Schuurhuis GJ; Ossenkoppele GJ
Haematologica; 2010 Jun; 95(6):1036-7. PubMed ID: 20421276
[No Abstract] [Full Text] [Related]
17. B-Lymphoid Blast Phase-Chronic Myeloid Leukemia: Current Therapeutics.
Yohannan B; George B
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233138
[TBL] [Abstract][Full Text] [Related]
18. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia.
Aumann K; Lassmann S; Schöpflin A; May AM; Wöhrle FU; Zeiser R; Waller CF; Hauschke D; Werner M; Brummer T
Hum Pathol; 2011 May; 42(5):719-26. PubMed ID: 21292300
[TBL] [Abstract][Full Text] [Related]
19. Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia.
Campiotti L; Grandi AM; Biotti MG; Ultori C; Solbiati F; Codari R; Venco A
Am J Hematol; 2007 Mar; 82(3):231-3. PubMed ID: 17022045
[TBL] [Abstract][Full Text] [Related]
20. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]